Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Lopez-Chavez

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nature Reviews. Clinical Oncology|July 2, 2010
Targeted therapies: Importance of patient selection for EGFR TKIs in lung cancerAriel Lopez-Chavez, Giuseppe Giaccone
Current Problems in Cancer|May 29, 2012
Systemic issues in small cell lung cancerAriel Lopez-Chavez, Alan Sandler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Young male with fanconi anemia and EGFR-mutant non-small-cell lung cancerElizabeth Cathcart-Rake, Ariel Lopez-Chavez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Reply to A. Stenzinger et alAnish Thomas, Ariel Lopez-Chavez, Giuseppe Giaccone
Anticancer Research|January 10, 2014
From platinum compounds to targeted therapies in advanced thoracic malignanciesMarko Jakopovic, Anish Thomas, Ariel Lopez-Chavez
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancerAriel Lopez-Chavez, Corey A Carter, Giuseppe Giaccone
Current Drug Targets|December 17, 2010
Criteria of evidence to move potential chemopreventive agents into late phase clinical trialsRonan J Kelly, Ariel Lopez-Chavez, Eva Szabo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Elderly former smoker with HRAS mutant non-small-cell lung cancerElizabeth Cathcart-Rake, Christopher Corless, David Sauer, et al.
Current Angiogenesis|February 10, 2021
HGF Airway Over-expression Leads to Enhanced Pulmonary Vascularization without Induction of VEGFCassandra Henry, Ariel Lopez-Chavez, Laura P Stabile, et al.
Psycho-Oncology|April 29, 2014
Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancerDonald R Sullivan, Linda Ganzini, Ariel Lopez-Chavez, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nature Reviews. Clinical Oncology|July 2, 2010
Targeted therapies: Importance of patient selection for EGFR TKIs in lung cancerAriel Lopez-Chavez, Giuseppe Giaccone
Current Problems in Cancer|May 29, 2012
Systemic issues in small cell lung cancerAriel Lopez-Chavez, Alan Sandler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Young male with fanconi anemia and EGFR-mutant non-small-cell lung cancerElizabeth Cathcart-Rake, Ariel Lopez-Chavez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Reply to A. Stenzinger et alAnish Thomas, Ariel Lopez-Chavez, Giuseppe Giaccone
Anticancer Research|January 10, 2014
From platinum compounds to targeted therapies in advanced thoracic malignanciesMarko Jakopovic, Anish Thomas, Ariel Lopez-Chavez
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancerAriel Lopez-Chavez, Corey A Carter, Giuseppe Giaccone
Current Drug Targets|December 17, 2010
Criteria of evidence to move potential chemopreventive agents into late phase clinical trialsRonan J Kelly, Ariel Lopez-Chavez, Eva Szabo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Elderly former smoker with HRAS mutant non-small-cell lung cancerElizabeth Cathcart-Rake, Christopher Corless, David Sauer, et al.
Current Angiogenesis|February 10, 2021
HGF Airway Over-expression Leads to Enhanced Pulmonary Vascularization without Induction of VEGFCassandra Henry, Ariel Lopez-Chavez, Laura P Stabile, et al.
Psycho-Oncology|April 29, 2014
Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancerDonald R Sullivan, Linda Ganzini, Ariel Lopez-Chavez, et al.
Pageof 3